Drug target · MTOR
mTORC1
Mechanistic target of rapamycin complex 1
1 compound in the CNS pipeline acts on mTORC1.
Compounds targeting mTORC1
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| Mefluleucine (NV-5138)primarySmall molecule | Activator | — | DiscontinuedTreatment-resistant depression | Navitor Pharmaceuticals, Inc. |